Agenda at a Glance
19th Orphan Drugs & Rare Diseases Global Congress 2023 Europe
EVENT INTRODUCTION
Paradigm Global Events is again proud to present our Orphan Drugs and Rare Diseases Global Congress 2023 Europe. It’s the 19th in the series of our Flagship tri-annual Orphan Drugs & Rare Diseases event. This congress will provide you with a comprehensive overview of the critical issues shaping the future of Orphan Drugs.
The COVID-19 Pandemic has impacted the lives of just about everyone, patients receiving
continuous treatment and care included. The Rare Disease community is already experiencing considerable challenges in achieving early and detailed diagnosis and having access to care and life-saving treatment, to chronic, highly complex, progressive, and severely disabling nature of their diseases, which generate specific care needs. Undoubtedly, during this crisis, the rare diseases community is experiencing unprecedented overall disruption even more…
According to a report by Fortune Business Insights, the Global Orphan Drugs Market size will emerge from the COVID-19 crisis at a moderate growth during the forecast period of 2020 to 2026. The global orphan drugs market size is projected to reach USD 340.84 billion by the end of 2027. As stated, the market was worth USD 151.00 billion in 2019 and will exhibit a CAGR of 10.5% during the forecast period, 2020-2027.
The current regulatory climate increasing the number of regulatory approvals, expanding
numbers of successful clinical trials related to these drugs, tremendous investments in R & D, and the interest and existence of several large-scale manufacturers, will create opportunities and contribute exponentially to the overall market growth.
The two-day Congress will provide an interactive, cutting edge, and comprehensive discussion and networking format led by key experts with intimate knowledge in the industry. Gain practical strategies and best practices on challenges, innovations, technologies, and concepts surrounding orphan drugs and rare diseases.
We look forward to welcoming you to the congress!
To view the conference agenda please click a buttons below. If you would like to request a PDF brochure by email, please fill out the form below and a member of our team will email one to you promptly.
GAIN THE LATEST INSIGHTS ON:
- Current Orphan Drugs landscape and implications of COVID19
- Major drivers in global rare disease market
- Key developmental strategies carried out and Influencing factors that may affect market share to stand out in this industry
- How the MHRA managing orphan medicinal products after Brexit?
- Finding innovative and alternative ways in funding the development of Orphan Drugs
- Patients perspective: what really matters to rare disease patients and caregivers?
- Key authorities facilitating development and approval of diagnostic products/services
- Coming Together in Developing Orphan Drugs and Crossing Borders
- Trends and evolution of Advanced Therapy Medicinal Products
- How Can the Developer and the Patient Assist in the Evolution and Development of Orphan Drugs to make it accessible to patients in a shorter period of time?
- Strategies to improve Access and Affordability
- What Do Developers Look for When Looking for an Outsourcing Partner?
- What Do Insurance Companies Think About Orphan Drugs? Will They Make Modifications to Their Policies to Support Patients with Rare Diseases?
- Opportunity to network with Peers, potential Partners and Investors
WHO SHOULD ATTEND
This congress is specially created for valued stakeholders in the Rare Disease community:
Presidents, Heads/Chiefs, VPs, Directors, and Managers in the area of:
- Clinical Research Organizations
- Research and Development
- Personalised Medicine
- Regenerative Medicine
- External R&D Innovation
- Innovative Medicine
- Rare and Ultra-Rare Diseases
- Cell and Gene Therapy
- Translational Science
- Molecular Geneticist
- Program Management
- Patient Advocacy Groups
- Public Affairs
- Medical Affairs
- Regulatory Affairs
- Market Access
- Pricing and Reimbursement
- Health Economics Outcomes Research
- Commercial Development
- Investments and Funding
- Product Specialist
- Global Strategic Services
- Business Planning and Operations
- Pharmacies
- Academia
- And many more...
Attendees Demographic
Our event partners and team of experts are recognized for creating and providing unique, innovative events. We open doors and create access to business opportunities for our clients. Our events are forum for discussion, learning, showcasing new technologies, innovations, new products and trends,solutions and concepts. Showcase your latest cutting-edge solutions, new products, technology, innovations and trend. Meet face to face with high level decision makers who are in a receptive mindset and actively seeking solutions and services.